 Context Therapeutics Inc NASDAQ:CNTX, a womens oncology company, said it is in a pivotal period following its debut on the Nasdaq and a recent private placement of its units that extends its cash runway into 2024. Releasing third-quarter results, the company told investors it also strengthened its leadership team with the addition of chief financial officer Jennifer Minai-Azary and chief legal officer Alex Levit, who was instrumental in getting Context Therapeutics NASDAQ:CNTX listed. 